<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04285684</url>
  </required_header>
  <id_info>
    <org_study_id>KetamineResearch</org_study_id>
    <nct_id>NCT04285684</nct_id>
  </id_info>
  <brief_title>The Pharmacokinetics of Ketamine in the Breast Milk of Lactating Women</brief_title>
  <acronym>KRF-LAC</acronym>
  <official_title>The Pharmacokinetics of Ketamine in the Breast Milk of Lactating Women: Quantification of Ketamine and Metabolites</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Ketamine Research Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Ketamine Research Foundation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Quantification of Ketamine in Breast Milk at 3 hour Intervals up to 30 hours-- obtained from&#xD;
      lactating women who receive 2 different Intramuscular injections of ketamine on two separate&#xD;
      days at least 5 days apart.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Quantification of Ketamine in Breast Milk at 3 hour Intervals up to 30 hours-- obtained from&#xD;
      lactating women who receive 2 different Intramuscular injections of ketamine on two separate&#xD;
      days at least 5 days apart: 0.5mg/kg and 1.0mg kg.&#xD;
&#xD;
      Women are required to have been breast feeding for at least 3 months and be healthy and on no&#xD;
      medications. Support is provided for the entire time at the site and for any at home pumping.&#xD;
      During the period of ketamine's influence, subjects are reclining and with 2 Investigators.&#xD;
      The initial subject's data will determine the length of time for pumping--most likely 12&#xD;
      hours as ketamine and the active principle metabolite have half-lives of less than 3 hours.&#xD;
      Determination of concentration of ketamine in breast milk is being done at the UCSF Clinical&#xD;
      lab with quantification of metabolites that are inactive as well. This research is of benefit&#xD;
      by providing lactating women information on potential exposure of infants/children to&#xD;
      ketamine. It will serve as a guide as KRF conducts research on postpartum depression and for&#xD;
      women at large using ketamine for psychiatric indications.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 20, 2019</start_date>
  <completion_date type="Actual">January 5, 2021</completion_date>
  <primary_completion_date type="Actual">January 5, 2021</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>4 subjects receiving 0.5mg/kg and 1.0mg/kg of ketamine at least 5 days apart with collection of breast milk by pumping at 3 hour intervals</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Pharmacodynamics of Ketamine in the Breast Milk of Lactating Women:</measure>
    <time_frame>12-24 hours at 3 hour intervals</time_frame>
    <description>Assessing the concentration of ketamine in breast milk</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">4</enrollment>
  <condition>Ketamine</condition>
  <condition>Lactation</condition>
  <arm_group>
    <arm_group_label>Ketamine, lactation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Lactating women--4 subjects, 2 dosage format: ketamine 0;5mg/kg and 1.0mg/kg IM at least 5 days apart.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ketamine in lactation</intervention_name>
    <description>2 dose IM by weight and assessing concentrations of ketamine in expressed milk at intervals</description>
    <arm_group_label>Ketamine, lactation</arm_group_label>
    <other_name>Assessing concentration of ketamine in breast milk at intervals</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:• Age 21-45&#xD;
&#xD;
          -  Postpartum with established lactation for a minimum of 3 months.&#xD;
&#xD;
          -  Ability to pump breast milk and to provide a reservoir for infant feeding prior to the&#xD;
             study; or acceptance of bottle feeding by the infant.&#xD;
&#xD;
          -  In good health-normal BP/P; afebrile-temp ascertained; review of systems by MD;&#xD;
             absence of diagnosed illnesses.&#xD;
&#xD;
          -  Not pregnant--Pregnancy tested for before each administration by urine assay.&#xD;
&#xD;
        Exclusion Criteria:• Hypertension with a BP greater than 145/90&#xD;
&#xD;
          -  Subjects must be off all psychiatric medications specifically; medications and&#xD;
             supplements, or evaluated by the PI for non-interference&#xD;
&#xD;
          -  No alcohol or other substances such as marijuana for 72 hours or more.&#xD;
&#xD;
          -  Weight &lt;50kg or &gt; 90kg.&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ketamine Research Foundation</name>
      <address>
        <city>San Anselmo</city>
        <state>California</state>
        <zip>94960</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Chang T, Glazko AJ. Biotransformation and disposition of ketamine. Int Anesthesiol Clin. 1974 Summer;12(2):157-77. Review.</citation>
    <PMID>4603048</PMID>
  </reference>
  <reference>
    <citation>Clements JA, Nimmo WS, Grant IS. Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans. J Pharm Sci. 1982 May;71(5):539-42.</citation>
    <PMID>7097501</PMID>
  </reference>
  <reference>
    <citation>Dore J, Turnipseed B, Dwyer S, Turnipseed A, Andries J, Ascani G, Monnette C, Huidekoper A, Strauss N, Wolfson P. Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy. J Psychoactive Drugs. 2019 Apr-Jun;51(2):189-198. doi: 10.1080/02791072.2019.1587556. Epub 2019 Mar 27.</citation>
    <PMID>30917760</PMID>
  </reference>
  <reference>
    <citation>Little B, Chang T, Chucot L, Dill WA, Enrile LL, Glazko AJ, Jassani M, Kretchmer H, Sweet AY. Study of ketamine as an obstetric anesthetic agent. Am J Obstet Gynecol. 1972 May 15;113(2):247-60.</citation>
    <PMID>4554554</PMID>
  </reference>
  <reference>
    <citation>Wan LB, Levitch CF, Perez AM, Brallier JW, Iosifescu DV, Chang LC, Foulkes A, Mathew SJ, Charney DS, Murrough JW. Ketamine safety and tolerability in clinical trials for treatment-resistant depression. J Clin Psychiatry. 2015 Mar;76(3):247-52. doi: 10.4088/JCP.13m08852.</citation>
    <PMID>25271445</PMID>
  </reference>
  <reference>
    <citation>Weber F, Wulf H, Gruber M, Biallas R. S-ketamine and s-norketamine plasma concentrations after nasal and i.v. administration in anesthetized children. Paediatr Anaesth. 2004 Dec;14(12):983-8.</citation>
    <PMID>15601346</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>February 24, 2020</study_first_submitted>
  <study_first_submitted_qc>February 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 26, 2020</study_first_posted>
  <last_update_submitted>July 29, 2021</last_update_submitted>
  <last_update_submitted_qc>July 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ketamine</keyword>
  <keyword>lactation</keyword>
  <keyword>postpartum depression</keyword>
  <keyword>breastfeeding</keyword>
  <keyword>infant exposure</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Publication of data in peer reviewed journal including all data; and available from KRF by request</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>6 months to 1 year</ipd_time_frame>
    <ipd_access_criteria>Public and researchers Health care professionals</ipd_access_criteria>
    <ipd_url>http://www.ketamineresearchfoundation.com</ipd_url>
  </patient_data>
  <pending_results>
    <submitted>September 8, 2021</submitted>
    <returned>September 29, 2021</returned>
    <submitted>October 7, 2021</submitted>
    <returned>November 4, 2021</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

